Inflation Rate in the United States remained unchanged at 2.70 percent in July. This dataset provides - United States Inflation Rate - actual values, historical data, forecast, chart, statistics, economic calendar and news.

Grass-Cast: Experimental Grassland Productivity Forecast for the Great Plains Grass-Cast uses almost 40 years of historical data on weather and vegetation growth in order to project grassland productivity in the Western U.S. More details on the projection model and method can be found at https://esajournals.onlinelibrary.wiley.com/doi/full/10.1002/ecs2.3280. Every spring, ranchers in the drought‐prone U.S. Great Plains face the same difficult challenge—trying to estimate how much forage will be available for livestock to graze during the upcoming summer grazing season. To reduce this uncertainty in predicting forage availability, we developed an innovative new grassland productivity forecast system, named Grass‐Cast, to provide science‐informed estimates of growing season aboveground net primary production (ANPP). Grass‐Cast uses over 30 yr of historical data including weather and the satellite‐derived normalized vegetation difference index (NDVI)—combined with ecosystem modeling and seasonal precipitation forecasts—to predict if rangelands in individual counties are likely to produce below‐normal, near‐normal, or above‐normal amounts of grass biomass (lbs/ac). Grass‐Cast also provides a view of rangeland productivity in the broader region, to assist in larger‐scale decision‐making—such as where forage resources for grazing might be more plentiful if a rancher’s own region is at risk of drought. Grass‐Cast is updated approximately every two weeks from April through July. Each Grass‐Cast forecast provides three scenarios of ANPP for the upcoming growing season based on different precipitation outlooks. Near real‐time 8‐d NDVI can be used to supplement Grass‐Cast in predicting cumulative growing season NDVI and ANPP starting in mid‐April for the Southern Great Plains and mid‐May to early June for the Central and Northern Great Plains. Here, we present the scientific basis and methods for Grass‐Cast along with the county‐level production forecasts from 2017 and 2018 for ten states in the U.S. Great Plains. The correlation between early growing season forecasts and the end‐of‐growing season ANPP estimate is >50% by late May or early June. In a retrospective evaluation, we compared Grass‐Cast end‐of‐growing season ANPP results to an independent dataset and found that the two agreed 69% of the time over a 20‐yr period. Although some predictive tools exist for forecasting upcoming growing season conditions, none predict actual productivity for the entire Great Plains. The Grass‐Cast system could be adapted to predict grassland ANPP outside of the Great Plains or to predict perennial biofuel grass production. This new experimental grassland forecast is the result of a collaboration between Colorado State University, U.S. Department of Agriculture (USDA), National Drought Mitigation Center, and the University of Arizona. Funding for this project was provided by the USDA Natural Resources Conservation Service (NRCS), USDA Agricultural Research Service (ARS), and the National Drought Mitigation Center. Watch for updates on the Grass-Cast website or on Twitter (@PeckAgEc). Project Contact: Dannele Peck, Director of the USDA Northern Plains Climate Hub, at dannele.peck@ars.usda.gov or 970-744-9043. Resources in this dataset:Resource Title: Cattle weight gain. File Name: Cattle_weight_gains.xlsxResource Description: Cattle weight gain data for Grass-Cast Database. Resource Title: NDVI. File Name: NDVI.xlsxResource Description: Annual NDVI growing season values for Grass-Cast sites. See readme for more information and NDVI_raw for the raw values. Resource Title: NDVI_raw . File Name: NDVI_raw.xlsxResource Description: Raw bimonthly NDVI values for Grass-Cast sites. Resource Title: ANPP. File Name: ANPP.xlsxResource Description: Dataset for annual aboveground net primary productivity (ANPP). Excel sheet is broken into two tabs, 1) 'readme' describing the data, 2) 'ANPP' with the actual data. Resource Title: Grass-Cast_sitelist . File Name: Grass-Cast_sitelist.xlsxResource Description: This provides a list of sites-studies that are currently incorporated into the Database as well as meta-data and contact info associated with the data sets. Includes a 'readme' tab and 'sitelist' tab. Resource Title: Grass-Cast_AgDataCommons_overview. File Name: Grass-Cast_AgDataCommons_download.htmlResource Description: Html document that shows database overview information. This document provides a glimpse of the data tables available within the data resource as well as respective meta-data tables. The R script (R markdown, .Rmd format) that generates the html file, and can be used to upload the Grass-Cast associated Ag Data Commons data files can be downloaded at the 'Grass-Cast R script' zip folder. The Grass-Cast files still need to be locally downloaded before use, but we are looking to make a download automated. Resource Title: Grass-Cast R script . File Name: R_access_script.zipResource Description: R script (in Rmarkdown [Rmd] format) for uploading and looking at Grass-Cast data.

Unemployment Rate in the United States increased to 4.20 percent in July from 4.10 percent in June of 2025. This dataset provides the latest reported value for - United States Unemployment Rate - plus previous releases, historical high and low, short-term forecast and long-term prediction, economic calendar, survey consensus and news.

Note: Reporting of new COVID-19 Case Surveillance data will be discontinued July 1, 2024, to align with the process of removing SARS-CoV-2 infections (COVID-19 cases) from the list of nationally notifiable diseases. Although these data will continue to be publicly available, the dataset will no longer be updated.

Authorizations to collect certain public health data expired at the end of the U.S. public health emergency declaration on May 11, 2023. The following jurisdictions discontinued COVID-19 case notifications to CDC: Iowa (11/8/21), Kansas (5/12/23), Kentucky (1/1/24), Louisiana (10/31/23), New Hampshire (5/23/23), and Oklahoma (5/2/23). Please note that these jurisdictions will not routinely send new case data after the dates indicated. As of 7/13/23, case notifications from Oregon will only include pediatric cases resulting in death.

This case surveillance public use dataset has 12 elements for all COVID-19 cases shared with CDC and includes demographics, any exposure history, disease severity indicators and outcomes, presence of any underlying medical conditions and risk behaviors, and no geographic data.

CDC has three COVID-19 case surveillance datasets:

• COVID-19 Case Surveillance Public Use Data with Geography: Public use, patient-level dataset with clinical data (including symptoms), demographics, and county and state of residence. (19 data elements)
• COVID-19 Case Surveillance Public Use Data: Public use, patient-level dataset with clinical and symptom data and demographics, with no geographic data. (12 data elements)
• COVID-19 Case Surveillance Restricted Access Detailed Data: Restricted access, patient-level dataset with clinical and symptom data, demographics, and state and county of residence. Access requires a registration process and a data use agreement. (33 data elements)

• Data elements can be found on the COVID-19 case report form located at www.cdc.gov/coronavirus/2019-ncov/downloads/pui-form.pdf.
• Data are considered provisional by CDC and are subject to change until the data are reconciled and verified with the state and territorial data providers.
• Some data cells are suppressed to protect individual privacy.
• The datasets will include all cases with the earliest date available in each record (date received by CDC or date related to illness/specimen collection) at least 14 days prior to the creation of the current datasets. This 14-day lag allows case reporting to be stabilized and ensures that time-dependent outcome data are accurately captured.
• Datasets are updated monthly.
• Datasets are created using CDC’s Policy on Public Health Research and Nonresearch Data Management and Access and include protections designed to protect individual privacy.
• For more information about data collection and reporting, please see https://www.cdc.gov/coronavirus/2019-ncov/covid-data/about-us-cases-deaths.html.
• For more information about the COVID-19 case surveillance data, please see https://www.cdc.gov/coronavirus/2019-ncov/covid-data/faq-surveillance.html
  

Overview

The COVID-19 case surveillance database includes individual-level data reported to U.S. states and autonomous reporting entities, including New York City and the District of Columbia (D.C.), as well as U.S. territories and affiliates. On April 5, 2020, COVID-19 was added to the Nationally Notifiable Condition List and classified as “immediately notifiable, urgent (within 24 hours)” by a Council of State and Territorial Epidemiologists (CSTE) Interim Position Statement (Interim-20-ID-01). CSTE updated the position statement on August 5, 2020, to clarify the interpretation of antigen detection tests and serologic test results within the case classification (Interim-20-ID-02). The statement also recommended that all states and territories enact laws to make COVID-19 reportable in their jurisdiction, and that jurisdictions conducting surveillance should submit case notifications to CDC. COVID-19 case surveillance data are collected by jurisdictions and reported voluntarily to CDC.

For more information: NNDSS Supports the COVID-19 Response | CDC.

The deidentified data in the “COVID-19 Case Surveillance Public Use Data” include demographic characteristics, any exposure history, disease severity indicators and outcomes, clinical data, laboratory diagnostic test results, and presence of any underlying medical conditions and risk behaviors. All data elements can be found on the COVID-19 case report form located at www.cdc.gov/coronavirus/2019-ncov/downloads/pui-form.pdf.

COVID-19 Case Reports

COVID-19 case reports have been routinely submitted using nationally standardized case reporting forms. On April 5, 2020, CSTE released an Interim Position Statement with national surveillance case definitions for COVID-19 included. Current versions of these case definitions are available here: https://ndc.services.cdc.gov/case-definitions/coronavirus-disease-2019-2021/.

All cases reported on or after were requested to be shared by public health departments to CDC using the standardized case definitions for laboratory-confirmed or probable cases. On May 5, 2020, the standardized case reporting form was revised. Case reporting using this new form is ongoing among U.S. states and territories.

Data are Considered Provisional

• The COVID-19 case surveillance data are dynamic; case reports can be modified at any time by the jurisdictions sharing COVID-19 data with CDC. CDC may update prior cases shared with CDC based on any updated information from jurisdictions. For instance, as new information is gathered about previously reported cases, health departments provide updated data to CDC. As more information and data become available, analyses might find changes in surveillance data and trends during a previously reported time window. Data may also be shared late with CDC due to the volume of COVID-19 cases.
• Annual finalized data: To create the final NNDSS data used in the annual tables, CDC works carefully with the reporting jurisdictions to reconcile the data received during the year until each state or territorial epidemiologist confirms that the data from their area are correct.
• Access Addressing Gaps in Public Health Reporting of Race and Ethnicity for COVID-19, a report from the Council of State and Territorial Epidemiologists, to better understand the challenges in completing race and ethnicity data for COVID-19 and recommendations for improvement.

Data Limitations

To learn more about the limitations in using case surveillance data, visit FAQ: COVID-19 Data and Surveillance.

Data Quality Assurance Procedures

CDC’s Case Surveillance Section routinely performs data quality assurance procedures (i.e., ongoing corrections and logic checks to address data errors). To date, the following data cleaning steps have been implemented:

• Questions that have been left unanswered (blank) on the case report form are reclassified to a Missing value, if applicable to the question. For example, in the question “Was the individual hospitalized?” where the possible answer choices include “Yes,” “No,” or “Unknown,” the blank value is recoded to Missing because the case report form did not include a response to the question.
• Logic checks are performed for date data. If an illogical date has been provided, CDC reviews the data with the reporting jurisdiction. For example, if a symptom onset date in the future is reported to CDC, this value is set to null until the reporting jurisdiction updates the date appropriately.
• Additional data quality processing to recode free text data is ongoing. Data on symptoms, race and ethnicity, and healthcare worker status have been prioritized.

Data Suppression

To prevent release of data that could be used to identify people, data cells are suppressed for low frequency (<5) records and indirect identifiers (e.g., date of first positive specimen). Suppression includes rare combinations of demographic characteristics (sex, age group, race/ethnicity). Suppressed values are re-coded to the NA answer option; records with data suppression are never removed.

For questions, please contact Ask SRRG (eocevent394@cdc.gov).

Additional COVID-19 Data

COVID-19 data are available to the public as summary or aggregate count files, including total counts of cases and deaths by state and by county. These

The DXY exchange rate fell to 97.8701 on August 15, 2025, down 0.39% from the previous session. Over the past month, the United States Dollar has weakened 0.53%, and is down by 4.43% over the last 12 months. United States Dollar - values, historical data, forecasts and news - updated on August of 2025.

After May 3, 2024, this dataset and webpage will no longer be updated because hospitals are no longer required to report data on COVID-19 hospital admissions, and hospital capacity and occupancy data, to HHS through CDC’s National Healthcare Safety Network. Data voluntarily reported to NHSN after May 1, 2024, will be available starting May 10, 2024, at COVID Data Tracker Hospitalizations.

The following dataset provides facility-level data for hospital utilization aggregated on a weekly basis (Sunday to Saturday). These are derived from reports with facility-level granularity across two main sources: (1) HHS TeleTracking, and (2) reporting provided directly to HHS Protect by state/territorial health departments on behalf of their healthcare facilities.

The hospital population includes all hospitals registered with Centers for Medicare & Medicaid Services (CMS) as of June 1, 2020. It includes non-CMS hospitals that have reported since July 15, 2020. It does not include psychiatric, rehabilitation, Indian Health Service (IHS) facilities, U.S. Department of Veterans Affairs (VA) facilities, Defense Health Agency (DHA) facilities, and religious non-medical facilities.

For a given entry, the term “collection_week” signifies the start of the period that is aggregated. For example, a “collection_week” of 2020-11-15 means the average/sum/coverage of the elements captured from that given facility starting and including Sunday, November 15, 2020, and ending and including reports for Saturday, November 21, 2020.

Reported elements include an append of either “_coverage”, “_sum”, or “_avg”.

• A “_coverage” append denotes how many times the facility reported that element during that collection week.
• A “_sum” append denotes the sum of the reports provided for that facility for that element during that collection week.
• A “_avg” append is the average of the reports provided for that facility for that element during that collection week.

The file will be updated weekly. No statistical analysis is applied to impute non-response. For averages, calculations are based on the number of values collected for a given hospital in that collection week. Suppression is applied to the file for sums and averages less than four (4). In these cases, the field will be replaced with “-999,999”.

A story page was created to display both corrected and raw datasets and can be accessed at this link: https://healthdata.gov/stories/s/nhgk-5gpv

This data is preliminary and subject to change as more data become available. Data is available starting on July 31, 2020.

Sometimes, reports for a given facility will be provided to both HHS TeleTracking and HHS Protect. When this occurs, to ensure that there are not duplicate reports, deduplication is applied according to prioritization rules within HHS Protect.

For influenza fields listed in the file, the current HHS guidance marks these fields as optional. As a result, coverage of these elements are varied.

For recent updates to the dataset, scroll to the bottom of the dataset description.

On May 3, 2021, the following fields have been added to this data set.

• hhs_ids
• previous_day_admission_adult_covid_confirmed_7_day_coverage
• previous_day_admission_pediatric_covid_confirmed_7_day_coverage
• previous_day_admission_adult_covid_suspected_7_day_coverage
• previous_day_admission_pediatric_covid_suspected_7_day_coverage
• previous_week_personnel_covid_vaccinated_doses_administered_7_day_sum
• total_personnel_covid_vaccinated_doses_none_7_day_sum
• total_personnel_covid_vaccinated_doses_one_7_day_sum
• total_personnel_covid_vaccinated_doses_all_7_day_sum
• previous_week_patients_covid_vaccinated_doses_one_7_day_sum
• previous_week_patients_covid_vaccinated_doses_all_7_day_sum

On May 8, 2021, this data set has been converted to a corrected data set. The corrections applied to this data set are to smooth out data anomalies caused by keyed in data errors. To help determine which records have had corrections made to it. An additional Boolean field called is_corrected has been added.

On May 13, 2021 Changed vaccination fields from sum to max or min fields. This reflects the maximum or minimum number reported for that metric in a given week.

On June 7, 2021 Changed vaccination fields from max or min fields to Wednesday reported only. This reflects that the number reported for that metric is only reported on Wednesdays in a given week.

On September 20, 2021, the following has been updated: The use of analytic dataset as a source.

On January 19, 2022, the following fields have been added to this dataset:

• inpatient_beds_used_covid_7_day_avg
• inpatient_beds_used_covid_7_day_sum
• inpatient_beds_used_covid_7_day_coverage

On April 28, 2022, the following pediatric fields have been added to this dataset:

• all_pediatric_inpatient_bed_occupied_7_day_avg
• all_pediatric_inpatient_bed_occupied_7_day_coverage
• all_pediatric_inpatient_bed_occupied_7_day_sum
• all_pediatric_inpatient_beds_7_day_avg
• all_pediatric_inpatient_beds_7_day_coverage
• all_pediatric_inpatient_beds_7_day_sum
• previous_day_admission_pediatric_covid_confirmed_0_4_7_day_sum
• previous_day_admission_pediatric_covid_confirmed_12_17_7_day_sum
• previous_day_admission_pediatric_covid_confirmed_5_11_7_day_sum
• previous_day_admission_pediatric_covid_confirmed_unknown_7_day_sum
• staffed_icu_pediatric_patients_confirmed_covid_7_day_avg
• staffed_icu_pediatric_patients_confirmed_covid_7_day_coverage
• staffed_icu_pediatric_patients_confirmed_covid_7_day_sum
• staffed_pediatric_icu_bed_occupancy_7_day_avg
• staffed_pediatric_icu_bed_occupancy_7_day_coverage
• staffed_pediatric_icu_bed_occupancy_7_day_sum
• total_staffed_pediatric_icu_beds_7_day_avg
• total_staffed_pediatric_icu_beds_7_day_coverage
• total_staffed_pediatric_icu_beds_7_day_sum

On October 24, 2022, the data includes more analytical calculations in efforts to provide a cleaner dataset. For a raw version of this dataset, please follow this link: https://healthdata.gov/Hospital/COVID-19-Reported-Patient-Impact-and-Hospital-Capa/uqq2-txqb

Due to changes in reporting requirements, after June 19, 2023, a collection week is defined as starting on a Sunday and ending on the next Saturday.

Annual Housing Unit Estimates for the United States, States, and Counties: April 1, 2010 to July 1, 2019 // Source: U.S. Census Bureau, Population Division // Note: The estimates are based on the 2010 Census and reflect changes to the April 1, 2010 housing units due to the Count Question Resolution program and geographic program revisions // Each year, the Census Bureau's Population and Housing Unit Estimates Program utilizes current data on new residential construction, placements of manufactured housing, and housing unit loss to calculate change in the housing stock since the most recent decennial census, and produces a time series of housing unit estimates. The annual time series of estimates begins with the most recent decennial census data and extends to the vintage year. The vintage year (e.g., V2019) refers to the final year of the time series. The reference date for all estimates is July 1, unless otherwise specified. With each new issue of estimates, the entire estimates series is revised. Additional information, including historical and intercensal estimates, evaluation estimates, demographic analysis, research papers, and methodology is available on website: https://www.census.gov/programs-surveys/popest.html.

This study presents the first large-scale assessment of cyanobacterial frequency and abundance at surface drinking water intakes across the United States. Public water systems serve drinking water to nearly 90% of the United States population. Cyanobacteria and their toxins may degrade the quality of finished drinking water and can lead to negative health consequences. Satellite imagery can serve as a cost-effective and consistent monitoring technique for surface cyanobacterial blooms in source waters and can provide drinking water treatment operators information for managing their systems. This study uses satellite imagery from the European Space Agency’s Ocean and Land Colour Instrument (OLCI) spanning June 2016 through April 2020. At 300-m spatial resolution, OLCI imagery can be used to monitor cyanobacteria in 685 drinking water sources across 285 lakes in 44 states. First, a subset of satellite data was compared to a subset of 99 responses submitted as part of the U.S. Environmental Protection Agency’s fourth Unregulated Contaminant Monitoring Rule (UCMR 4). These UCMR 4 quantitative responses included visual observations of algal bloom presence and absence near drinking water intakes from March 2018 through November 2019. Overall agreement between satellite imagery and UCMR 4 qualitative responses was high at over 94% with a Kappa coefficient of 0.70. Next, temporal frequency of cyanobacterial blooms at all resolvable drinking water sources was assessed. In 2019, bloom frequency averaged 2% and peaked at 100%, where 100% indicated a bloom was always present at the source waters when satellite imagery was available. Monthly cyanobacterial abundances were used to assess short-term trends across all resolvable drinking water sources. Generally, 2016-2020 was an insufficient time period for observing changes at these source waters; On average, a decade of data would be required for observed trends to outweigh variability in the data. However, five source waters did demonstrate a sustained short-term trend, with one increasing in cyanobacterial abundance from June 2016 to April 2020 and four decreasing. This dataset is not publicly accessible because: EPA cannot release personally identifiable information regarding living individuals, according to the Privacy Act and the Freedom of Information Act (FOIA). This dataset contains information about human research subjects. Because there is potential to identify individual participants and disclose personal information, either alone or in combination with other datasets, individual level data are not appropriate to post for public access. Restricted access may be granted to authorized persons by contacting the party listed. It can be accessed through the following means: Katherine Foreman, Office of Ground Water and Drinking Water. Format: Assessing temporal frequency of cyanobacterial blooms at drining water intakes using imagery from the Sentinel-3A satellite sensor. This dataset is associated with the following publication: Coffer, M., B. Schaeffer, K. Foreman, A. Porteous, K.A. Loftin, R.P. Stumpf, P.J. Werdell, E. Urquhart, R. Albert, and J. Darling. Assessing cyanobacterial frequency and abundance at surface waters near drinking water intakes across the United States. WATER RESEARCH. Elsevier Science Ltd, New York, NY, USA, 201: 117377, (2021).

Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes

Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022.

Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases among people who received additional or booster doses were reported from 31 jurisdictions; 30 jurisdictions also reported data on deaths among people who received one or more additional or booster dose; 28 jurisdictions reported cases among people who received two or more additional or booster doses; and 26 jurisdictions reported deaths among people who received two or more additional or booster doses. This list will be updated as more jurisdictions participate. Incidence rate estimates: Weekly age-specific incidence rates by vaccination status were calculated as the number of cases or deaths divided by the number of people vaccinated with a primary series, overall or with/without a booster dose (cumulative) or unvaccinated (obtained by subtracting the cumulative number of people vaccinated with a primary series and partially vaccinated people from the 2019 U.S. intercensal population estimates) and multiplied by 100,000. Overall incidence rates were age-standardized using the 2000 U.S. Census standard population. To estimate population counts for ages 6 months through 1 year, half of the single-year population counts for ages 0 through 1 year were used. All rates are plotted by positive specimen collection date to reflect when incident infections occurred. For the primary series analysis, age-standardized rates include ages 12 years and older from April 4, 2021 through December 4, 2021, ages 5 years and older from December 5, 2021 through July 30, 2022 and ages 6 months and older from July 31, 2022 onwards. For the booster dose analysis, age-standardized rates include ages 18 years and older from September 19, 2021 through December 25, 2021, ages 12 years and older from December 26, 2021, and ages 5 years and older from June 5, 2022 onwards. Small numbers could contribute to less precision when calculating death rates among some groups. Continuity correction: A continuity correction has been applied to the denominators by capping the percent population coverage at 95%. To do this, we assumed that at least 5% of each age group would always be unvaccinated in each jurisdiction. Adding this correction ensures that there is always a reasonable denominator for the unvaccinated population that would prevent incidence and death rates from growing unrealistically large due to potential overestimates of vaccination coverage. Incidence rate ratios (IRRs): IRRs for the past one month were calculated by dividing the average weekly incidence rates among unvaccinated people by that among people vaccinated with a primary series either overall or with a booster dose. Publications: Scobie HM, Johnson AG, Suthar AB, et al. Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1284–1290. Johnson AG, Amin AB, Ali AR, et al. COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021. MMWR Morb Mortal Wkly Rep 2022;71:132–138. Johnson AG, Linde L, Ali AR, et al. COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022. MMWR Morb Mortal Wkly Rep 2023;72:145–152. Johnson AG, Linde L, Payne AB, et al. Notes from the Field: Comparison of COVID-19 Mortality Rates Among Adults Aged ≥65 Years Who Were Unvaccinated and Those Who Received a Bivalent Booster Dose Within the Preceding 6 Months — 20 U.S. Jurisdictions, September 18, 2022–April 1, 2023. MMWR Morb Mortal Wkly Rep 2023;72:667–669.

This dataset contains discharge measurements collected in the Lower Mississippi River, Louisiana, USA. Measurements were taken on the following dates: 24 May 2022, 23 August 2022, 4 April 2023, 17 April 2023, 18 April 2023, 15 May 2023, 16 May 2023, 12 June 2023, 13 June 2023, 25 July 2023, 26 July 2023, 19 September 2023, 30 January 2024, 16 February 2024, and 27 February 2024. Data were collected to determine the discharge of the Mississippi River and to assess its relationship to Neptune Pass, currently the largest new distributary of the river. Measurements were obtained using an Acoustic Doppler Current Profiler (ADCP). The data collected on 24 May 2022 and 16 February 2024 were acquired by Kolker and colleagues as part of this study, while the remaining data were collected by the U.S. Army Corps of Engineers during routine discharge surveys and shared with the authors. Additional discharge data from the USGS Belle Chasse gauge (site number 07374525) were obtained from https://waterdata.usgs.gov. The study area is located in southeastern Louisiana, with geographical bounds approximately spanning from 29.847°N, -90.023°W (northwest) to 29.129°N, -89.075°W (southeast).

The State of the Climate is a collection of periodic summaries recapping climate-related occurrences on both a global and national scale. The State of the Climate Monthly Overview - National Snow & Ice report provides an analysis of snow and ice in the United States, placing the data into a historical perspective. Topics include snow cover extent and snowpack; the period of record for snow cover extent is 1967 to the present. Significant events and storms are also covered. Reports are generated monthly for all snow months in the U.S. (October-April, occasionally September and May) beginning with October 2002. Additional annual analyses focused on the July through June Northern Hemisphere "snow season", as opposed to the calendar year, are available beginning in 2008.

Link to the ScienceBase Item Summary page for the item described by this metadata record. Service Protocol: Link to the ScienceBase Item Summary page for the item described by this metadata record. Application Profile: Web Browser. Link Function: information

Retail Sales in the United States increased 0.60 percent in June of 2025 over the previous month. This dataset provides - U.S. December Retail Sales Increased More Than Forecast - actual values, historical data, forecast, chart, statistics, economic calendar and news.

Note: After May 3, 2024, this dataset will no longer be updated because hospitals are no longer required to report data on COVID-19 hospital admissions, hospital capacity, or occupancy data to HHS through CDC’s National Healthcare Safety Network (NHSN). The related CDC COVID Data Tracker site was revised or retired on May 10, 2023.

Note: May 3,2024: Due to incomplete or missing hospital data received for the April 21,2024 through April 27, 2024 reporting period, the COVID-19 Hospital Admissions Level could not be calculated for CNMI and will be reported as “NA” or “Not Available” in the COVID-19 Hospital Admissions Level data released on May 3, 2024.

This dataset represents COVID-19 hospitalization data and metrics aggregated to county or county-equivalent, for all counties or county-equivalents (including territories) in the United States as of the initial date of reporting for each weekly metric. COVID-19 hospitalization data are reported to CDC’s National Healthcare Safety Network, which monitors national and local trends in healthcare system stress, capacity, and community disease levels for approximately 6,000 hospitals in the United States. Data reported by hospitals to NHSN and included in this dataset represent aggregated counts and include metrics capturing information specific to COVID-19 hospital admissions, and inpatient and ICU bed capacity occupancy.

Reporting information:

• As of December 15, 2022, COVID-19 hospital data are required to be reported to NHSN, which monitors national and local trends in healthcare system stress, capacity, and community disease levels for approximately 6,000 hospitals in the United States. Data reported by hospitals to NHSN represent aggregated counts and include metrics capturing information specific to hospital capacity, occupancy, hospitalizations, and admissions. Prior to December 15, 2022, hospitals reported data directly to the U.S. Department of Health and Human Services (HHS) or via a state submission for collection in the HHS Unified Hospital Data Surveillance System (UHDSS).
• While CDC reviews these data for errors and corrects those found, some reporting errors might still exist within the data. To minimize errors and inconsistencies in data reported, CDC removes outliers before calculating the metrics. CDC and partners work with reporters to correct these errors and update the data in subsequent weeks.
• Many hospital subtypes, including acute care and critical access hospitals, as well as Veterans Administration, Defense Health Agency, and Indian Health Service hospitals, are included in the metric calculations provided in this report. Psychiatric, rehabilitation, and religious non-medical hospital types are excluded from calculations.
• Data are aggregated and displayed for hospitals with the same Centers for Medicare and Medicaid Services (CMS) Certification Number (CCN), which are assigned by CMS to counties based on the CMS Provider of Services files.
• Full details on COVID-19 hospital data reporting guidance can be found here: https://www.hhs.gov/sites/default/files/covid-19-faqs-hospitals-hospital-laboratory-acute-care-facility-data-reporting.pdf

• County-level hospital data are derived using calculations performed at the Health Service Area (HSA) level. An HSA is defined by CDC’s National Center for Health Statistics as a geographic area containing at least one county which is self-contained with respect to the population’s provision of routine hospital care. Every county in the United States is assigned to an HSA, and each HSA must contain at least one hospital. Therefore, use of HSAs in the calculation of local hospital metrics allows for more accurate characterization of the relationship between health care utilization and health status at the local level.
• Data presented at the county-level represent admissions, hospital inpatient and ICU bed capacity and occupancy among hospitals within the selected HSA. Therefore, admissions, capacity, and occupancy are not limited to residents of the selected HSA.
• For all county-level hospital metrics listed below the values are calculated first for the entire HSA, and then the HSA-level value is then applied to each county within the HSA.
• For all county-level hospital metrics listed below the values are calculated first for the entire HSA, and then the HSA-level value is then applied to each county within the HSA.

• Time period: data for the previous MMWR week (Sunday-Saturday) will update weekly on Mondays as soon as they are reviewed and verified, usually before 8 pm ET. Updates will occur the following day when reporting coincides with a federal holiday. Note: Weekly updates might be delayed due to delays in reporting. All data are provisional. Because these provisional counts are subject to change, including updates to data reported previously, adjustments can occur. Data may be updated since original publication due to delays in reporting (to account for data received after a given Thursday publication) or data quality corrections.
• New hospital admissions (count): Total number of admissions of patients with laboratory-confirmed COVID-19 in the previous week (including both adult and pediatric admissions) in the entire jurisdiction
• New Hospital Admissions Rate Value (Admissions per 100k): Total number of new admissions of patients with laboratory-confirmed COVID-19 in the past week (including both adult and pediatric admissions) for the entire jurisdiction divided by 2019 intercensal population estimate for that jurisdiction multiplied by 100,000. (Note: This metric is used to determine each county’s COVID-19 Hospital Admissions Level for a given week).
• New COVID-19 Hospital Admissions Rate Level: qualitative value of new COVID-19 hospital admissions rate level [Low, Medium, High, Insufficient Data]
• New hospital admissions percent change from prior week: Percent change in the current weekly total new admissions of patients with laboratory-confirmed COVID-19 per 100,000 population compared with the prior week.
• New hospital admissions percent change from prior week level: Qualitative value of percent change in hospital admissions rate from prior week [Substantial decrease, Moderate decrease, Stable, Moderate increase, Substantial increase, Insufficient data]
• COVID-19 Inpatient Bed Occupancy Value: Percentage of all staffed inpatient beds occupied by patients with laboratory-confirmed COVID-19 (including both adult and pediatric patients) within the in the entire jurisdiction is calculated as an average of valid daily values within the past week (e.g., if only three valid values, the average of those three is taken). Averages are separately calculated for the daily numerators (patients hospitalized with confirmed COVID-19) and denominators (staffed inpatient beds). The average percentage can then be taken as the ratio of these two values for the entire jurisdiction.
• COVID-19 Inpatient Bed Occupancy Level: Qualitative value of inpatient beds occupied by COVID-19 patients level [Minimal, Low, Moderate, Substantial, High, Insufficient data]
• COVID-19 Inpatient Bed Occupancy percent change from prior week: The absolute change in the percent of staffed inpatient beds occupied by patients with laboratory-confirmed COVID-19 represents the week-over-week absolute difference between the average occupancy of patients with confirmed COVID-19 in staffed inpatient beds in the past week, compared with the prior week, in the entire jurisdiction.
• COVID-19 ICU Bed Occupancy Value: Percentage of all staffed inpatient beds occupied by adult patients with confirmed COVID-19 within the entire jurisdiction is calculated as an average of valid daily values within the past week (e.g., if only three valid values, the average of those three is taken). Averages are separately calculated for the daily numerators (adult patients hospitalized with confirmed COVID-19) and denominators (staffed adult ICU beds). The average percentage can then be taken as the ratio of these two values for the entire jurisdiction.
• COVID-19 ICU Bed Occupancy Level: Qualitative value of ICU beds occupied by COVID-19 patients level [Minimal, Low, Moderate, Substantial, High, Insufficient data]
• COVID-19 ICU Bed Occupancy percent change from prior week: The absolute change in the percent of staffed ICU beds occupied by patients with laboratory-confirmed COVID-19 represents the week-over-week absolute difference between the average occupancy of patients with confirmed COVID-19 in staffed adult ICU beds for the past week, compared with the prior week, in the in the entire jurisdiction.
• For all metrics, if there are no data in the specified locality for a given week, the metric value is displayed as “insufficient data”.

Notes: June 15, 2023: Due to incomplete or missing hospital data received for the June 4, 2023, through June 10, 2023, reporting period, the COVID-19 Hospital Admissions Level could not be calculated for CNMI and AS and will be reported as “NA” or “Not Available” in the COVID-19 Hospital Admissions Level data released on June 15, 2023.

July 10, 2023: Due to incomplete or missing hospital data received for the June 25, 2023, through July 1, 2023, reporting period, the COVID-19 Hospital Admissions Level could not be calculated for CNMI and AS and will be reported as “NA” or “Not Available” in the COVID-19 Hospital Admissions Level data released on July 10, 2023.

July 17, 2023: Due to incomplete or missing hospital data received for the July 2, 2023, through July 8, 2023, reporting

Consumer Price Index CPI in the United States increased to 323.05 points in July from 322.56 points in June of 2025. This dataset provides the latest reported value for - United States Consumer Price Index (CPI) - plus previous releases, historical high and low, short-term forecast and long-term prediction, economic calendar, survey consensus and news.

This table contains 27 series, with data starting from 1981 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (1 item: Canada) Type of currency (27 items: Australian dollar, monthly average; Brazilian real, monthly average; Chinese renminbi, monthly average; European euro, monthly average; ...).

Money Supply M2 in the United States increased to 21942 USD Billion in May from 21862.40 USD Billion in April of 2025. This dataset provides - United States Money Supply M2 - actual values, historical data, forecast, chart, statistics, economic calendar and news.

Core consumer prices in the United States increased 3.10 percent in July of 2025 over the same month in the previous year. This dataset provides - United States Core Inflation Rate - actual values, historical data, forecast, chart, statistics, economic calendar and news.

Non Farm Payrolls in the United States increased by 73 thousand in July of 2025. This dataset provides the latest reported value for - United States Non Farm Payrolls - plus previous releases, historical high and low, short-term forecast and long-term prediction, economic calendar, survey consensus and news.

The EUR/USD exchange rate rose to 1.1704 on August 15, 2025, up 0.46% from the previous session. Over the past month, the Euro US Dollar Exchange Rate - EUR/USD has strengthened 0.59%, and is up by 6.13% over the last 12 months. Euro US Dollar Exchange Rate - EUR/USD - values, historical data, forecasts and news - updated on August of 2025.